Dedicated to enabling precision medicine.scientific innovation.medical
discovery.global collaboration.
DNAnexus® has built the world’s most secure, trusted cloud platform and global network for scientific collaboration and accelerated discovery. We partner with customers to tackle the world’s most exciting opportunities in human health and beyond.
Enabling Progress
1 Powerful & Purpose-Built Platform
Rapid, Scalable & Secure Data Science
Using genomics in the discovery and development of new medicines and diagnostics requires the ability to manage high volumes of data in a secure, compliant, production-ready environment. DNAnexus provides a platform that facilitates the integration of the genetic data with other data types and enables collaboration globally.
2 A true global network
Connecting Pharmaceutical, Medical Centers & Research Partners
Progress in science and medicine accelerates when researchers collaborate around responsibly shared datasets. As the complexity and scale of data increases, collaboration becomes more difficult to manage. DNAnexus enables distributed research teams access to the same data and analysis tools to advance scientific discovery.
3 Move beyond Genomics
Extract Knowledge from Diverse Data
Insights from genomic data are revealed more often when multiple data types are analyzed together. DNAnexus helps advance medical discovery by bringing genomic, multi-omics, and clinical data securely together on a single scalable platform.
Enabling Discovery
Latest News, Case Studies, White Papers, Webinars & More.
Sign up for our monthly newsletter to learn about DNAnexus initiatives and gain exclusive access to new tools and product launches.
ENABLING COLLABORATIVE SCIENCE
In collaboration with Microsoft, DNAnexus Platform forms the foundation of St. Jude Cloud, providing researchers access to the world’s largest public repository of pediatric cancer genomic data to accelerate data mining, analysis, and visualization capabilities.
DNAnexus is proud to power precisionFDA, a community platform for next-generation sequencing assay evaluation and regulatory science exploration.
PRESS & NEWS
MARCH 7, 2023
DNAnexus included in Fast Company's 10 most innovative biotech companies of 2023
-
Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases.JAMES R. DOWNING
President & CEO
St. Jude Children's Research Hospital -
The best thing you can do with DNAnexus is give them a problem to solve.JEFFREY REID
Executive Director, Head of Genome Informatics
Regeneron Genetics Center